Growth, weight gain and BMI in virally suppressed children on antiretroviral therapy with specific reference to dolutegravir.

Adolescent girls gained weight to a greater extent than expected but independently of ART. We found no association between dolutegravir alone or combined with tenofovir alafenamide fumarate (TAF) and excessive weight gain. Height development was within normal range.